SARS-CoV-2 Nucleoprotein Recombinant Protein (ELISA Control), Unconjugated, Human

Catalog Number: ASB-OPAQ00226
Article Name: SARS-CoV-2 Nucleoprotein Recombinant Protein (ELISA Control), Unconjugated, Human
Biozol Catalog Number: ASB-OPAQ00226
Supplier Catalog Number: OPAQ00226
Alternative Catalog Number: ASB-OPAQ00226-2000UL, ASB-OPAQ00226-200UL, ASB-OPAQ00226-20UL
Manufacturer: Aviva
Host: Human
Category: Kits/Assays
Application: ELISA
Species Reactivity: Virus
Conjugation: Unconjugated
Alternative Names: N, NC, NP, ORF9, sars-cov-2
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is an enveloped, positive-sense, single-stranded RNA virus that causes coronavirus disease 2019 (COVID-19). Virus particles include the RNA genetic material and structural proteins needed for invasion of host cells. Once inside the cell the infecting RNA is used to encode structural proteins that make up virus particles, nonstructural proteins that direct virus assembly, transcription, replication and host control and accessory proteins whose function has not been determined.~ The structural proteins of SARS-CoV-2 include the envelope protein (E), spike or surface glycoprotein (S), membrane protein (M) and the nucleocapsid protein (N). The nucleocapsid phosphoprotein is a structural protein that binds to, protects the viral RNA genome and is involved in packaging the RNA into virus particles. The N protein has been suggested as an antiviral drug target. (Source NCBI). Control antigen for SARS-CoV-2 (COVID-19) assays. Contains C-terminal His tag used for purification.
Concentration: 0.5 mg/mL
Molecular Weight: 46 kDa
NCBI: 43740575
Form: Liquid. 1X PBS, 0.02% NaN3